NDT Advance Access originally published online on November 2, 2004
Nephrology Dialysis Transplantation 2005 20(1):155-160; doi:10.1093/ndt/gfh520
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrol Dial Transplant Vol. 20 No. 1 © ERA-EDTA 2004; all rights reserved
Original Article
Mid-dilution on-line haemodiafiltration in a standard dialyser configuration
1 Nephrology, University Hospital, Montpellier, France and 2 Nephros Inc., New York, USA
Correspondence and offprint requests to: Bernard Canaud, CHU Montpellier, Lapeyronie Hospital, Department of Nephrology, 371, Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: b-canaud{at}chu-montpellier.fr
Background. Mid-dilution haemodiafiltration (HDF) results in an improved middle molecule removal compared with standard HDF. The OLp
rTM MD 190 haemodiafilter represents a new dialyser design exclusively for mid-dilution on-line HDF. Compared with standard haemodialysers, structural changes in the headers allow the infusion of high replacement fluid volumes after a first post-dilution and before a second pre-dilution stage.
Methods. We compared in vitro the new device [blood flow (QB) 400 ml/min, substitution flow (QS) 100 and 200 ml/min, dialysate flow (QD) 800 ml/min] with a conventional high-flux dialyser of the same surface area in haemodialysis (HD) (QD 500 ml/min) and post-dilution HDF (at QS 60, QD = 500 ml/min and at QS 100, QD = 800 ml/min) modes. Subsequently, we performed an initial clinical application of the new device in six mid-dilution HDF treatments of five end-stage renal disease patients (QB 400 ml/min, QS 200 ml/min, QD 800 ml/min, treatment duration 205±23 min).
Results. In vitro urea and ß2-microglobulin clearances in mid-dilution HDF were, respectively, 309.2±5.5 and 144.4±15.2 ml/min (QS 100) and 321.6±4.1 and 204.9±4.1 ml/min (QS 200), compared with 278.6± 17.2 and 94.0±7.6 ml/min in HD, and 310.8±10.2 and 123.0±6.5 ml/min (QS 60) and 323.6±11.2 and 158.0±10.3 ml/min (QS 100) in post-dilution HDF. The in vivo trials showed the clinical utility of the device and confirmed the in vitro data: urea and ß2-microglobulin clearances were, respectively, 324.6± 10.9 and 207.9±29.3 ml/min, while reduction ratios were 75.0±5.5 and 83.6±4.7%.
Conclusion. Our preliminary results need confirmation in a prospective cross-over study. However, the Nephros MD 190 haemodiafilter promises to be a true technological step ahead in terms of improved ß2-microglobulin removal.
Keywords: haemodiafiltration; haemodialyser design; middle molecules; mid-dilution; on-line substitution fluid
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. A. Pedrini, A. Feliciani, S. Zerbi, G. Cozzi, and P. Ruggiero Optimization of mid-dilution haemodiafiltration: technique and performance Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2816 - 2824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Santoro, E. Ferramosca, E. Mancini, C. Monari, M. Varasani, L. Sereni, and M. Wratten Reverse mid-dilution: new way to remove small and middle molecules as well as phosphate with high intrafilter convective clearance Nephrol. Dial. Transplant., July 1, 2007; 22(7): 2000 - 2005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. De Smet, A. Dhondt, S. Eloot, F. Galli, M. A. Waterloos, and R. Vanholder Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes Nephrol. Dial. Transplant., July 1, 2007; 22(7): 2006 - 2012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Feliciani, M. A. Riva, S. Zerbi, P. Ruggiero, A. R. Plati, G. Cozzi, and L. A. Pedrini New strategies in haemodiafiltration (HDF): prospective comparative analysis between on-line mixed HDF and mid-dilution HDF Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1672 - 1679. [Abstract] [Full Text] [PDF]
|
|